{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T22:39:56Z","timestamp":1769121596778,"version":"3.49.0"},"reference-count":46,"publisher":"Japanese Circulation Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2017]]},"DOI":"10.1253\/circj.cj-17-0234","type":"journal-article","created":{"date-parts":[[2017,6,12]],"date-time":"2017-06-12T18:08:19Z","timestamp":1497290899000},"page":"1798-1806","source":"Crossref","is-referenced-by-count":18,"title":["Survival and Heart Failure Hospitalization in Patients With Cardiac Resynchronization Therapy With or Without a Defibrillator for Primary Prevention in Japan\u3000\u2015 Analysis of the Japan Cardiac Device Treatment Registry Database \u2015"],"prefix":"10.1253","volume":"81","author":[{"given":"Hisashi","family":"Yokoshiki","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, Yamaguchi Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Mitsuhashi","sequence":"additional","affiliation":[{"name":"Cardiovascular Medicine, Jichi Medical University Saitama Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Furushima","sequence":"additional","affiliation":[{"name":"Furushima Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Sekiguchi","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Faculty of Medicine, University of Tsukuba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuyuki","family":"Manaka","sequence":"additional","affiliation":[{"name":"Asakusa Heart Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Nishii","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Ueyama","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine and Clinical Sciences, Yamaguchi Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norishige","family":"Morita","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Tokai University Hachioji Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Okamura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Nitta","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenzo","family":"Hirao","sequence":"additional","affiliation":[{"name":"Heart Rhythm Center, Tokyo Medical and Dental University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Okumura","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Saiseikai Kumamoto Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the Members of the Implantable Cardioverter-Defibrillator (ICD) Committee of the Japanese Heart Rhythm Society","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al. Cardiac resynchronization in chronic heart failure. <i>N Engl J Med<\/i> 2002; 346: 1845\u20131853.","DOI":"10.1056\/NEJMoa013168"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. <i>N Engl J Med<\/i> 2004; 350: 2140\u20132150.","DOI":"10.1056\/NEJMoa032423"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. <i>N Engl J Med<\/i> 2005; 352: 1539\u20131549.","DOI":"10.1056\/NEJMoa050496"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Gold MR, Daubert JC, Abraham WT, Hassager C, Dinerman JL, Hudnall JH, et al. Implantable defibrillators improve survival in patients with mildly symptomatic heart failure receiving cardiac resynchronization therapy: Analysis of the long-term follow-up of remodeling in systolic left ventricular dysfunction (reverse). <i>Circ Arrhythm Electrophysiol<\/i> 2013; 6: 1163\u20131168.","DOI":"10.1161\/CIRCEP.113.000570"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Schuchert A, Muto C, Maounis T, Frank R, Boulogne E, Polauck A, et al. Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker. <i>Europace<\/i> 2013; 15: 71\u201376.","DOI":"10.1093\/europace\/eus247"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Shimizu A, Mitsuhashi T, Furushima H, Sekiguchi Y, Manaka T, Nishii N, et al. Current status of cardiac resynchronization therapy with defibrillators and factors influencing its prognosis in Japan. <i>J Arrhythm<\/i> 2013; 29: 168\u2013174.","DOI":"10.1016\/j.joa.2013.04.006"},{"key":"7","unstructured":"7. Shimizu A, Nitta T, Kurita T, Imai K, Kimura T, Kobayashi Y, et al. Current status of implantable defibrillator devices in patients with left ventricular dysfunction: The first report from the online registry database. <i>J Arrhythm<\/i> 2008; 24: 133\u2013140."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Shimizu A, Nitta T, Kurita T, Imai K, Kobayashi Y, Soejima K, et al. Actual conditions of implantable defibrillator therapy over 5 years in Japan. <i>J Arrhythm<\/i> 2012; 28: 263\u2013272.","DOI":"10.1016\/j.joa.2012.03.014"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Yokoshiki H, Shimizu A, Mitsuhashi T, Furushima H, Sekiguchi Y, Manaka T, et al. Trends and determinant factors in the use of cardiac resynchronization therapy devices in Japan: Analysis of the Japan Cardiac Device Treatment Registry database. <i>J Arrhythm<\/i> 2016; 32: 486\u2013490.","DOI":"10.1016\/j.joa.2016.04.002"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Goldenberg I, Vyas AK, Hall WJ, Moss AJ, Wang H, He H, et al. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. <i>J Am Coll Cardiol<\/i> 2008; 51: 288\u2013296.","DOI":"10.1016\/j.jacc.2007.08.058"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia: Multicenter Automatic Defibrillator Implantation Trial Investigators. <i>N Engl J Med<\/i> 1996; 335: 1933\u20131940.","DOI":"10.1056\/NEJM199612263352601"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. <i>N Engl J Med<\/i> 2002; 346: 877\u2013883.","DOI":"10.1056\/NEJMoa013474"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Bansch D, Antz M, Boczor S, Volkmer M, Tebbenjohanns J, Seidl K, et al. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: The Cardiomyopathy Trial (CAT). <i>Circulation<\/i> 2002; 105: 1453\u20131458.","DOI":"10.1161\/01.CIR.0000012350.99718.AD"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. <i>N Engl J Med<\/i> 2004; 350: 2151\u20132158.","DOI":"10.1056\/NEJMoa033088"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kober L, Thune JJ, Nielsen JC, Haarbo J, Videbaek L, Korup E, et al. Defibrillator implantation in patients with nonischemic systolic heart failure. <i>N Engl J Med<\/i> 2016; 375: 1221\u20131230.","DOI":"10.1056\/NEJMoa1608029"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Strickberger SA, Hummel JD, Bartlett TG, Frumin HI, Schuger CD, Beau SL, et al. Amiodarone versus implantable cardioverter-defibrillator: Randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia \u2013 AMIOVIRT. <i>J Am Coll Cardiol<\/i> 2003; 41: 1707\u20131712.","DOI":"10.1016\/S0735-1097(03)00297-3"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Lampert R, McPherson CA, Clancy JF, Caulin-Glaser TL, Rosenfeld LE, Batsford WP. Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implantable cardioverter-defibrillators. <i>J Am Coll Cardiol<\/i> 2004; 43: 2293\u20132299.","DOI":"10.1016\/j.jacc.2004.03.031"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Barra S, Providencia R, Tang A, Heck P, Virdee M, Agarwal S. Importance of implantable cardioverter-defibrillator back-up in cardiac resynchronization therapy recipients: A systematic review and meta-analysis. <i>J Am Heart Assoc<\/i> 2015; 4: e002539.","DOI":"10.1161\/JAHA.115.002539"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kutyifa V, Geller L, Bogyi P, Zima E, Aktas MK, Ozcan EE, et al. Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart failure patients: Results of a high-volume, single-centre experience. <i>European J Heart Fail<\/i> 2014; 16: 1323\u20131330.","DOI":"10.1002\/ejhf.185"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Witt CT, Kronborg MB, Nohr EA, Mortensen PT, Gerdes C, Jensen HK, et al. Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy. <i>Europace<\/i> 2016; 18: 413\u2013419.","DOI":"10.1093\/europace\/euv212"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Barra S, Looi KL, Gajendragadkar PR, Khan FZ, Virdee M, Agarwal S. Applicability of a risk score for prediction of the long-term benefit of the implantable cardioverter defibrillator in patients receiving cardiac resynchronization therapy. <i>Europace<\/i> 2016; 18: 1187\u20131193.","DOI":"10.1093\/europace\/euv352"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Munir MB, Althouse AD, Rijal S, Shah MB, Abu Daya H, Adelstein E, et al. Clinical characteristics and outcomes of older cardiac resynchronization therapy recipients using a pacemaker versus a defibrillator. <i>J Cardiovasc Electrophysiol<\/i> 2016; 27: 730\u2013734.","DOI":"10.1111\/jce.12951"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Jiang M, He B, Zhang Q. Comparison of CRT and CRT-D in heart failure: Systematic review of controlled trials. <i>Int J Cardiol<\/i> 2012; 158: 39\u201345.","DOI":"10.1016\/j.ijcard.2010.12.091"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Chen J, Johnson G, Hellkamp AS, Anderson J, Mark DB, Lee KL, et al. Rapid-rate nonsustained ventricular tachycardia found on implantable cardioverter-defibrillator interrogation: Relationship to outcomes in the SCD-HEFT (Sudden Cardiac Death In Heart Failure Trial). <i>J Am Coll Cardiol<\/i> 2013; 61: 2161\u20132168.","DOI":"10.1016\/j.jacc.2013.02.046"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Barra S, Boveda S, Providencia R, Sadoul N, Duehmke R, Reitan C, et al. Adding defibrillation therapy to cardiac resynchronization on the basis of the myocardial substrate. <i>J Am Coll Cardiol<\/i> 2017; 69: 1669\u20131678.","DOI":"10.1016\/j.jacc.2017.01.042"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26. Yokoshiki H, Mitsuyama H, Watanabe M, Mitsuhashi T, Shimizu A. Cardiac resynchronization therapy in ischemic and non-ischemic cardiomyopathy. <i>J Arrhythm<\/i>, doi:10.1016\/j.joa.2017.03.002.","DOI":"10.1016\/j.joa.2017.03.002"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Effect of metoprolol cr\/xl in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). <i>Lancet<\/i> 1999; 353: 2001\u20132007.","DOI":"10.1016\/S0140-6736(99)04440-2"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial. <i>Lancet<\/i> 1999; 353: 9\u201313.","DOI":"10.1016\/S0140-6736(98)11181-9"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure: U.S. Carvedilol Heart Failure Study Group. <i>N Engl J Med<\/i> 1996; 334: 1349\u20131355.","DOI":"10.1056\/NEJM199605233342101"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (Consensus). <i>N Engl J Med<\/i> 1987; 316: 1429\u20131435.","DOI":"10.1056\/NEJM198706043162301"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. SOLVD Investigators, Yusuf S, Pitt B, Davis CE, Hood WB, Cohn JN. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. <i>N Engl J Med<\/i> 1991; 325: 293\u2013302.","DOI":"10.1056\/NEJM199108013250501"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Granger CB, McMurray JJ, Yusuf S, Held P, Michelson EL, Olofsson B, et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: The CHARM-Alternative trial. <i>Lancet<\/i> 2003; 362: 772\u2013776.","DOI":"10.1016\/S0140-6736(03)14284-5"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. McMurray JJ, Ostergren J, Swedberg K, Granger CB, Held P, Michelson EL, et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: The CHARM-Added trial. <i>Lancet<\/i> 2003; 362: 767\u2013771.","DOI":"10.1016\/S0140-6736(03)14283-3"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. <i>N Engl J Med<\/i> 2003; 348: 1309\u20131321.","DOI":"10.1056\/NEJMoa030207"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure: Randomized aldactone evaluation study investigators. <i>N Engl J Med<\/i> 1999; 341: 709\u2013717.","DOI":"10.1056\/NEJM199909023411001"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Hindricks G, Taborsky M, Glikson M, Heinrich U, Schumacher B, Katz A, et al. Implant-based multiparameter telemonitoring of patients with heart failure (in-time): A randomised controlled trial. <i>Lancet<\/i> 2014; 384: 583\u2013590.","DOI":"10.1016\/S0140-6736(14)61176-4"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. De Simone A, Leoni L, Luzi M, Amellone C, Stabile G, La Rocca V, et al. Remote monitoring improves outcome after ICD implantation: The clinical efficacy in the management of heart failure (EFFECT) study. <i>Europace<\/i> 2015; 17: 1267\u20131275.","DOI":"10.1093\/europace\/euu318"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Saxon LA, Hayes DL, Gilliam FR, Heidenreich PA, Day J, Seth M, et al. Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: The ALTITUDE survival study. <i>Circulation<\/i> 2010; 122: 2359\u20132367.","DOI":"10.1161\/CIRCULATIONAHA.110.960633"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Marijon E, Leclercq C, Narayanan K, Boveda S, Klug D, Lacaze-Gadonneix J, et al. Causes-of-death analysis of patients with cardiac resynchronization therapy: An analysis of the CeRtiTuDe cohort study. <i>Eur Heart J<\/i> 2015; 36: 2767\u20132776.","DOI":"10.1093\/eurheartj\/ehv455"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Kutyifa V, Huth Ruwald AC, Aktas MK, Jons C, McNitt S, Polonsky B, et al. Clinical impact, safety, and efficacy of single- versus dual-coil ICD leads in MADIT-CRT. <i>J Cardiovasc Electrophysiol<\/i> 2013; 24: 1246\u20131252.","DOI":"10.1111\/jce.12219"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Gold MR, Higgins S, Klein R, Gilliam FR, Kopelman H, Hessen S, et al. Efficacy and temporal stability of reduced safety margins for ventricular defibrillation: Primary results from the low energy safety study (LESS). <i>Circulation<\/i> 2002; 105: 2043\u20132048.","DOI":"10.1161\/01.CIR.0000015508.59749.F5"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Mizukami K, Yokoshiki H, Mitsuyama H, Watanabe M, Tenma T, Matsui Y, et al. Predictors of high defibrillation threshold in patients with implantable cardioverter-defibillator using a transvenous dual-coil lead. <i>Circ J<\/i> 2015; 79: 77\u201384.","DOI":"10.1253\/circj.CJ-14-0860"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Tseng ZH, Hayward RM, Clark NM, Mulvanny CG, Colburn BJ, Ursell PC, et al. Sudden death in patients with cardiac implantable electronic devices. <i>JAMA Intern Med<\/i> 2015; 175: 1342\u20131350.","DOI":"10.1001\/jamainternmed.2015.2641"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Bayes de Luna A, Coumel P, Leclercq JF. Ambulatory sudden cardiac death: Mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. <i>Am Heart J<\/i> 1989; 117: 151\u2013159.","DOI":"10.1016\/0002-8703(89)90670-4"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Watanabe E, Tanabe T, Osaka M, Chishaki A, Takase B, Niwano S, et al. Sudden cardiac arrest recorded during holter monitoring: Prevalence, antecedent electrical events, and outcomes. <i>Heart Rhythm<\/i> 2014; 11: 1418\u20131425.","DOI":"10.1016\/j.hrthm.2014.04.036"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Carson P, Anand I, O\u2019Connor C, Jaski B, Steinberg J, Lwin A, et al. Mode of death in advanced heart failure: The comparison of medical, pacing, and defibrillation therapies in heart failure (COMPANION) trial. <i>J Am Coll Cardiol<\/i> 2005; 46: 2329\u20132334.","DOI":"10.1016\/j.jacc.2005.09.016"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/81\/12\/81_CJ-17-0234\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T19:36:58Z","timestamp":1569440218000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/81\/12\/81_CJ-17-0234\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-17-0234","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}